DNA Diagnostic Tests Spat Has Congress Eyeing New FDA Powers

June 19, 2019

The next wave of diagnostics that can scan a patient’s DNA for a host of genetic diseases needs to be better regulated to ensure the tests deliver what they promise, according to the Food and Drug Administration (FDA). Those regulators’ struggle to exert oversight could inform upcoming legislation to give the FDA even more authority.